Product Information
AZELASTIN-FLUTIC 137-50 MCG SPR is a generic product labeled by Apotex Corp., priced at $2.0210 per GM under NDC 60505095303. Its NADAC has been published 333 times since May 20, 2020.
FDA first approved this application on Apr 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
137; 50 ug/1; ug/1
Manufacturer
Apotex Corp.NDC
60505095303
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA207712FDA Approved
4/28/2017
TE Code
AB
On Market Since
3/2/2020
Pharmacological Classes
Price Statistics
The NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has been published 333 times since May 20, 2020, and over the history we have for it it has declined 69.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0210 per GM |
|---|---|
| All-time high | $6.6885 (Jun 10, 2020) |
| All-time low | $2.0210 (Sep 23, 2026) |
| 52-week high | $3.1882 |
| 52-week low | $2.0210 |
| Median price | $3.4127 |
| Average price | $3.8684 |
| Largest weekly change | +16.0% (Dec 22, 2021) |
| Weeks tracked | 333 |
| Tracking since | May 20, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Azelastine hydrochloride and Fluticasone propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Azelastine hydrochloride and Fluticasone propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AZELASTIN-FLUTIC 137-50 MCG SPR?
The current National Average Drug Acquisition Cost (NADAC) for AZELASTIN-FLUTIC 137-50 MCG SPR, manufactured by Apotex Corp., is $2.0210 per GM (NDC 60505095303), effective Sep 30, 2026.
How has the price of AZELASTIN-FLUTIC 137-50 MCG SPR changed over time?
Over the history we have for it, the NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has declined 69.8%. It has been tracked across 333 weekly CMS publications since May 20, 2020.
What are the highest and lowest recorded NADAC prices for AZELASTIN-FLUTIC 137-50 MCG SPR?
Since May 20, 2020, the NADAC for AZELASTIN-FLUTIC 137-50 MCG SPR has ranged from a low of $2.0210 (Sep 23, 2026) to a high of $6.6885 (Jun 10, 2020), with a median of $3.4127 per GM.
Are there cheaper alternatives to AZELASTIN-FLUTIC 137-50 MCG SPR?
No other NADAC-published product currently shares the active ingredient and strength of AZELASTIN-FLUTIC 137-50 MCG SPR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures AZELASTIN-FLUTIC 137-50 MCG SPR?
AZELASTIN-FLUTIC 137-50 MCG SPR (NDC 60505095303) is labeled by Apotex Corp., and CMS classifies it as a generic product.